Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COVID-19 vaccination safety and immunity study in autoimmune rheumatic diseases
RBR-108fyykdNot yet recruiting
- Sponsor
- Federal University of São Paulo
- Start
- Apr 2021
- Countries
- 1
01
Overview
Open-label, single-arm trial in coronavirus disease 2019 (COVID-19), sponsored by Federal University of São Paulo. Primary endpoints: Safety after COVID-19 vaccination, Effectiveness after COVID-19 vaccination and 1 more. Planned start Apr 2021; status: not yet recruiting.
02
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on RBR-108fyykd.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-108fyykd.